HHS OIG To Probe Hospital Use Of 503B Compounded Sterile Drugs
Inside Health Policy (subscription)-Nov 21, 2016
HHS' Office of Inspector General plans to investigate how 503B outsourcing facilities and hospitals produce and use compounded sterile drugs and how many of ...
No comments:
Post a Comment